SIL1 and Marinesco-Sjogren syndrome: Although this review does not address induced pluripotent stem cells (iPSCs), they represent a promising avenue for capturing human-specific disease mechanisms, particularly for the 40% of patients with MSS who do not have identified SIL1 mutations.